Cite
HARVARD Citation
Siano, M. et al. (n.d.). 2861 Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC). European journal of cancer. pp. S576-S577. [Online].